Croda International (CRDA)

Sector:

Industrial Chemicals

Index:

FTSE 100

3,452.00p
   
  • Change Today:
      55.00p
  • 52 Week High: 5,092.00
  • 52 Week Low: 3,332.00
  • Currency: UK Pounds
  • Shares Issued: 139.64m
  • Volume: 110,860
  • Market Cap: £4,820.22m
  • RiskGrade: 108
  • Beta: 1.25

CRDA Overview

Croda International PLC is a life sciences and consumer care company. Its segments include Consumer Care, Life Sciences and Industrial Specialties. The Consumer Care segment is focused on high-value niches in the markets of skin care, hair care, solar protection, fabric and surface care, and fragrances. The Consumer Care comprises four businesses: beauty care, beauty actives, home care and fragrances and flavors. Its Life Sciences segment is engaged in providing quality health care solutions, protecting crops and enhancing seeds. The Company is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein and nucleic acid delivery platforms. It is engaged in offering ingredients that improve the performance and delivery of crop formulations.

1 Day Chart (24-12-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.2% 0.0%
Div Cover 1.5 1.2
Op Mrgn 14.6% 16.6%
ROCE 13.2%  
Latest F'cast
P/E 20.6 25.2
PEG n/a n/a
Pr/Revenue 2.8 2.9
Pr/Book 2.0  
Latest F'cast
Revenue -18.9% -3.5%
PBT -69.7% 14.6%
EPS -38.4% -18.4%
DPS 0.9% 1.0%

CRDA Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 1,377.70 302.30 185.00p 27.7 n/a -3% 90.00p 1.8%
31-Dec-20 1,390.30 269.50 175.50p 37.6 n/a -5% 91.00p 1.4%
31-Dec-21 1,889.60 411.50 250.00p 40.5 1.0 +42% 100.00p 1.0%
31-Dec-22 2,089.30 780.00 272.00p 24.3 2.7 +9% 108.00p 1.6%
31-Dec-23 1,694.50 236.30 167.60p 30.1 n/a -38% 109.00p 2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CRDA Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 1,635.19 270.89 136.78p 25.2 n/a -18% 110.09p 0.0%
31-Dec-25 1,719.51 309.97 157.22p 22.0 1.5 +15% 112.98p 0.0%
31-Dec-26 1,827.26 359.00 182.20p 18.9 1.2 +16% 120.23p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

CRDA Company Announcements

Director/PDMR Shareholding 11-Dec-2024 15:09 RNS
Director/PDMR Shareholding 11-Dec-2024 13:54 RNS
Holding(s) in Company 09-Dec-2024 14:36 RNS

CRDA ShareCast News

London close: Stocks maintain gains ahead of UK ... 11-Nov-2024 ShareCast
Croda retains guidance, but FX movements to damp... 11-Nov-2024 ShareCast
London close: Stocks slip as investors digest US... 05-Sep-2024 ShareCast

CRDA Top Newspaper Links

Chemical firm Croda warns sterling rise will den... 25-Jun-2014 Express & Star
Croda warns strong pound to hit profits 25-Jun-2014 Telegraph
Second Croda deal for Aquapharm 13-Jul-2011 The Scotsman

Latest CRDA Director Deals

Traded Action Notifier PriceAmountValue
10-Dec-24 Buy Danuta Gray 3,486.00p 575 £20,044.50
10-Dec-24 Transfer From Steve Foots 0.000p 4 £0.00
10-Dec-24 Buy Steve Foots 3,464.00p 4 £138.56

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

CRDA Market Data

Currency UK Pounds
Share Price 3,452.00p
Change Today 55.00p
% Change 1.62 %
52 Week High 5,092.00
52 Week Low 3,332.00
Volume 110,860
Shares Issued 139.64m
Market Cap £4,820.22m
Beta 1.25
RiskGrade 108

CRDA Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.65% below the market average52.65% below the market average52.65% below the market average52.65% below the market average52.65% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average
Price Trend
61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income
18.97% below the market average18.97% below the market average18.97% below the market average18.97% below the market average18.97% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
84.63% below the market average84.63% below the market average84.63% below the market average84.63% below the market average84.63% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 8
Sell 0
Strong Sell 1
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CRDA Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Sep-24 18-Apr-24
Paid 08-Oct-24 29-May-24
Amount 47.00p 62.00p

Trades for 24-Dec-2024

Time Volume / Share Price
12:35 67,271 @ 3,452.00p
12:35 148 @ 3,452.00p
12:35 13 @ 3,452.00p
12:35 238 @ 3,452.00p
12:35 510 @ 3,452.00p

CRDA Key Personnel

CFO Stephen Oxley

Top of Page